Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / answer-to-counterclaims.docx
answer-to-counterclaims.docx
Parties
Counterclaim Defendant Penterra Pharmaceuticals Corp
Harkness LLP
Penterra Pharmaceuticals Corp
Boston Kenmore Realty Corp
See Cambridge Biotech Corp
M. Rourke
Polk LLP
Dates
May 14, 2021
July 1, 2017
June 30, 2022
January 12, 2018
September 14, 2020
March 8, 2021
February 15, 2021
June 4, 2021
Amounts
$9.5
$11.2
$14.8
$18.3
$16.1
$6.4
$35
Obligations
3 of the EDA provides, in relevant part: "Distributor shall not actively solicit orders for, or deliver, the Products outside the Territory without Supplier's prior written consent
NINTH AFFIRMATIVE DEFENSE: Mitigation of Damages To the extent Vantage claims to have suffered any damages, which Penterra denies, such damages are barred or must be reduced by Vantage's failure to take reasonable steps to mitigate its alleged losses
Nothing in this Answer shall be construed as a waiver of any defense or objection available to Penterra